Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: An in vitro study with the reverse hemolytic plaque assay

Journal of Endocrinological Investigation

Volumn 22, Issue 9, 1999, Pages 671-680

  Thodou, Eleni ^a,d   Kontogeorgos, G ^a   Kyrodimou, E ^a   Salla, H ^a   Ramyar, L ^e   Vamvassakis, E ^b   Piaditis, G ^a   Anagnostopoulos, N ^a   Tzanis, S ^c   Levedis, A ^a   Rologis, D ^c   Asa, S L ^e  

^a KAT HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c HYGEIA HOSPITAL   (Greece)

^d G GENNIMATAS GENERAL HOSPITAL   (Greece)

^e NONE

Author keywords

Adenoma; In vitro; Octreotide; Pituitary; RHPA; Tissue culture

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; PROLACTIN;

ACROMEGALY; ARTICLE; CLINICAL ARTICLE; ELECTRON MICROSCOPY; FEMALE; GROWTH HORMONE RELEASE; HEMOLYTIC PLAQUE ASSAY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PROLACTIN RELEASE; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0032710483     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343628     Document Type: Article

References (33)

1. nd Series, Armed Forces Institute of Pathology, Washington, DC, 1986, p. 1.
2. Kontogeorgos G. Pituitary tumours. In: Polak J.M. (Ed.), Diagnostic histopathology of neuroendocrine tumors. Churchill Livingstone, London, 1993, p. 227.
3. Asa S.L., Kovacs K. Histological classification of pituitary disorders. Clin. Endocrinol. Metab. 1983, 12: 567-596.
4. Ezzat S., Kontogeorgos G., Redelmeier D.A., Horvath E., Harris A.G., Kovacs K. In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide. Eur. J. Endocrinol. 1995, 133: 686-690.
5. Kontogeorgos G., Asa S.L., Kovacs K., Smyth S.S., Singer W. Production of a-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro. Acta Endocrinol. (Copenh.) 1993, 129: 565-572.
6. Lloyd R.V., Anagnostou M.C., Barkan A.L., Chandler W.F. Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunohistochemistry. J. Clin. Endocrinol. Metab. 1988, 66: 1103-1110.
7. Hofland L.J., van Koetsveld P.M., van Vroonhoven C.C.J., Stefanko S.Z., Lamberts S.W.J. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone. J. Clin. Endocrinol. Metab. 1989, 68: 613-620.
8. Hofland L.J., Velkeniers B., van Koetsveld P.M., Hooghe-Peters E.L., Lamberts S.W.J. The relationship between growth hormone (GH) messenger ribonucleic acid levels and hormone release from individual cells derived from human GH-secreting pituitary adenomas. Clin. Endocrinol. (Oxf.) 1991, 34: 5-11.
9. Yamada S., Asa S.L., Kovacs K., Muller P., Smyth H.S. Analysis of hormone secretion by clinically nonfunctioning human pituitary adenomas using the reverse hemolytic plaque assay. J. Clin. Endocrinol. Metab. 1989, 68: 73-80.
10. Yamada S., Aiba T., Hattori A., Suzuki T., Asa S.L. Kovacs K. Reverse hemolytic plaque assay. Electron microscopic observation of plaque-forming single adenoma cells in GH producing adenomas. Pathol. Res. Pract. 1991, 187: 546-551.
11. Yamada S., Sano T., Stefaneanu L., Kovacs K., Aiba T., Sawano S., Shishiba Y. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. J. Clin. Endocrinol. Metab. 1993, 76: 352-356.
12. Ezzat S., Walpola I.A., Ramyar L., Smyth H.S., Asa S.L. Membrane-anchored expression of transforming growth factor-a in human pituitary adenoma cells. J. Clin. Endocrinol. Metab. 1995, 80: 534-539.
13. Ezzat S., Smyth H.S., Ramyar L., Asa S.L. Heterogeneous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J. Clin. Endocrinol. Metab. 1995, 80: 878-884.
14. Kojima Y., Arita J., Kuwana N., Kimura F. Dopamine responsiveness of human pituitary prolactinoma cells as determined by the reverse hemolytic plaque assay. J. Endocrinol. 1995, 42: 355-360.
15. Hardy J. Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler P.O., Ross G.T. (Eds.), Diagnosis and treatment of pituitary tumors. Int. Congress Series No 303, Excerpta Medica, Amsterdam, 1973, p. 179.
16. Thodou E., Ramyar L., Cohen A., Singer W., Asa S.L. A serum-free system for primary cultures of human pituitary adenomas. Endocr. Pathol. 1995, 6: 289-299.
17. Smith P.P., Luque E.H., Neill J.D. Detection and measurement of secretion from individual neuroendocrine cells using the reverse hemolytic plaque assay. Meth. Enzymol. 1986, 124: 443-465.
18. Spada A., Arosio M., Bochicchio D., Bazzoni N., Vallar L, Basseti M., Faglia G. Clinical, biochemical and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J. Clin. Endocrinol. Metab. 1990, 71: 1421-1426.
19. Li J., Stefaneanu L., Kovacs K., Horvath E., Smyth H.S. Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH and PRL producing human pituitary adenomas. Virchows Arch. 1993, 422: 193-201.
20. Davis J.R.E. Heterogeneity of growth hormone production in human pituitary tumour cells. Clin. Endocrinol. (Oxf.) 1991, 34: 3-4.
21. Lamberts S.W.J, Verleun T., Hofland L.J., Del Pozo E. A comparison between the effects of SMS 201-995, bromocriptine and a combination of both drugs on hormone release by the cultured pituitary tumor cells of acromegalic patients. Clin. Endocrinol. (Oxf.) 1987, 27: 11-23.
22. Lamberts S.W.J. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr. Rev. 1988, 9: 417-436.
23. Ezzat S., Snyder P.J., Young W.F., Boyajy L.D., Newman C., Klibansky A., Molitch M.E., Boyd A.E. Sheeler L., Cook D.M. Octreotide treatment of acromegaly. A randomized, multicenter study. Ann. Intern. Med. 1992, 117: 711-718.
24. Hofland L.J., Velkeniers B., vd Lely A.J., van Koetsveld P.M., Kazemzadeh M., Waaijers M., Hooghe-Peters E.L., Lamberts S.W.J. Long-term in vitro treatment of human growth-hormone (GH)-secreting pituitary adenoma cells with octreotide causes accumulation of intracellular GH and GH mRNa levels. Clin. Endocrinol. (Oxf.) 1992, 37: 240-248.
25. Tindall G.T., Kovacs K., Horvath E., Thorner M.O. Human prolactin-producing adenomas and bromocriptine: A histological, immunocytochemical, ultrastructural and morphometric study. J. Clin. Endocrinol. Metab. 1982, 55: 1178-1183.
26. Levy A., Lightman S.L. Quantitative in situ hybridization histochemistry studies on growth hormone (GH) gene expression in acromegalic somatotrophs: effects of somatostatin, GH-releasing factor and cortisol. J. Mol. Endocrinol. 1988, 1: 19-26.
27. Davis J.R.E., Wilson E.M., Vidal M.E., Johnson A.P., Lynch S.S., Sheppard M.C. Regulation of growth hormone secretion and messenger ribonucleic acid accumulation in human somatotropinoma cells in vitro. J. Clin. Endocrinol. Metab. 1989, 69: 704-708.
28. Ezzat S., Horvath E., Harris A.G., Kovacs K. Morphological effects of octreotide on growth hormone-producing pituitary adenomas. J. Clin. Endocrinol. Metab. 1994, 79: 113-118.
29. Betherat J., Chanson P., Dewailly D., Dupy M., Jaquet P., Peillon F., Epelbaum J. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. J. Clin. Endocrinol. Metab. 1993, 77: 1577-1583.
30. Reubi J.C., Landolt A.M. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin re-ceptor status. J. Clin. Endocrinol. Metab. 1989, 68: 844-850.
31. Ur E., Mather S.J, Bomangi J., Ellison D., Britton K.E., Grossman A.B., Wass J.A., Besser G.M. Pituitary imaging using a labeled somatostatin analogue in acromegaly. Clin. Endocrinol. (Oxf.) 1992, 36: 147-150.
32. Greenman Y., Melmed S. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J. Clin. Endocrinol. Metab. 1994, 79: 724-729.
33. Wise P.M., Larson G.H., Scarbrough K., Chiu S Weiland N.C., Lloyd J.M., Hinkle D.A., Cai A. Simultaneous monitoring of pituitary hormone secretion and gene expression within individual cells. Biol. Reprod. 1992, 46: 178-185.